The U.S. Dept. of Health & Human Services issued a subpoena to Novartis (NYSE:NVS) subsidiary Alcon Inc., seeking documents related to its marketing practices and payments to physicians.
The Sept. 23 subpoena is part of an HHS investigation probe into possible health care fraud, Novartis said in a regulatory filing.